gemcitabine has been researched along with dimethyl sulfoxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altinoz, MA; Bilir, A; Guneri, AD | 1 |
| Alessio, E; Baas, P; Beijnen, JH; Burgers, SA; Leijen, S; Pluim, D; Sava, G; Schellens, JH; Tibben, M; van Werkhoven, E | 1 |
1 trial(s) available for gemcitabine and dimethyl sulfoxide
| Article | Year |
|---|---|
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Dimethyl Sulfoxide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Organometallic Compounds; Ruthenium; Ruthenium Compounds; Treatment Outcome | 2015 |
1 other study(ies) available for gemcitabine and dimethyl sulfoxide
| Article | Year |
|---|---|
Acetaminophen and DMSO modulate growth and gemcitabine cytotoxicity in FM3A breast cancer cells in vitro.
Topics: Acetaminophen; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Breast Neoplasms; Cell Division; Cyclooxygenase Inhibitors; Deoxycytidine; Dimethyl Sulfoxide; Gemcitabine; Humans; Ribonucleotide Reductases; S Phase; Time Factors; Tumor Cells, Cultured | 2004 |